Physician

Micki N Ly, M.D.

According to 2025 Medicare claims, Micki Ly, M.D. (NPI: 1346299435) practices dermatology in the Kahului-Wailuku, HI market, with the plurality of this provider's patient population coming from Maui, HI. Ly uses personal NPI as billing NPI and primary practice location at 96732-3513.

Ly's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 186 traditional Medicare patients, billed 1,524 HCPCS/CPT codes, and received $157,890 in Medicare payments. The top billing code was 10061 (Complicated or multiple drainage of skin abscess). Part D data shows 2,211 prescription claims across 408 beneficiaries totaling $304,256 in drug costs, led by Dupixent Syringe (Dupilumab). Open Payments data shows 28 records totaling $447. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $29,314 to $304,256. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$102K$204K2015 Medicare payment: $164,274 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $146,151 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $171,903 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $192,823 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $204,027 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $169,219 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $169,804 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $201,255 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $193,957 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $157,890 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151981,796$164,274
20162031,682$146,151
20172111,882$171,903
20182462,152$192,823
20192552,308$204,027
20202161,913$169,219
20212021,717$169,804
20222231,938$201,255
20232291,887$193,957
20241861,524$157,890

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$162K$323K2015 Drug cost: $29,314 (USD; Tot_Drug_Cst)2016 Drug cost: $31,106 (USD; Tot_Drug_Cst)2017 Drug cost: $58,443 (USD; Tot_Drug_Cst)2018 Drug cost: $35,989 (USD; Tot_Drug_Cst)2019 Drug cost: $64,759 (USD; Tot_Drug_Cst)2020 Drug cost: $191,254 (USD; Tot_Drug_Cst)2021 Drug cost: $194,674 (USD; Tot_Drug_Cst)2022 Drug cost: $265,359 (USD; Tot_Drug_Cst)2023 Drug cost: $323,282 (USD; Tot_Drug_Cst)2024 Drug cost: $304,256 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015160678$29,314
2016139637$31,106
2017193946$58,443
20182301,104$35,989
20192511,326$64,759
20202871,507$191,254
20212841,417$194,674
20223841,850$265,359
20234202,223$323,282
20244082,211$304,256

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
10061Complicated or multiple drainage of skin abscess42109$173
17004Destruction of precancer skin growth, 15 or more growths127501$132
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more146563$67
99203New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more7878$63
11102Biopsy of related skin growth, first growth5074$60

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Dupixent SyringeDupilumab16448$60,709
XolairOmalizumab14412$21,597
Triamcinolone AcetonideTriamcinolone Acetonide45813,004$5,238
CephalexinCephalexin2744,003$3,869
MethotrexateMethotrexate Sodium2898,791$3,099

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.28$447ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Micki N. Ly, M.D.?

Tedicare shows public-source Medicare data for Micki N. Ly, M.D. (NPI 1346299435), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Micki N. Ly, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Micki N. Ly, M.D.?

A separate primary affiliated billing organization is not shown for this profile in the available data.

Does Micki N. Ly, M.D. have Open Payments data?

Micki N. Ly, M.D. has 28 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.